Amphastar Pharmaceuticals
AMPH
AMPH
109 hedge funds and large institutions have $397M invested in Amphastar Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 40 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
18% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 40
Holders
109
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$5.34M | |
| 2 | +$2.96M | |
| 3 | +$2.85M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2.07M |
| 5 |
ACM
Argent Capital Management
St Louis,
Missouri
|
+$2.02M |
Top Sellers
| 1 | -$6.26M | |
| 2 | -$2M | |
| 3 | -$1.34M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.24M |
| 5 |
Citigroup
New York
|
-$1.03M |